Etan Orgel, MD, MS News

A multi-center clinical trial demonstrates how new reporting tools help symptom management and intervention for children receiving cancer treatment.

CHLA faculty will share new research on pediatric blood cancers and diseases at the American Society of Hematology Annual Meeting in San Diego.

A CHLA clinical trial finds that N-acetylcysteine may be a promising next-generation therapy to reduce the risk of cisplatin-induced hearing loss.

The ambitions of pediatric researchers are global in scale: Beyond patients at their own hospital, they look to shape national and international standards for pediatric care.

A CHLA oncologist led a pivotal clinical trial leading to the approval of the first drug to prevent cisplatin hearing loss in children.

In the News - Awards and Honors - New Faces

Yervant Demirjian’s son is nearly free of leukemia. In gratitude, Demirjian has made a generous planned gift to Children’s Hospital Los Angeles.

Risk of detecting cancer cells decreased by 70% after one month of treatment